Use of the levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas (2004)
- Authors:
- USP affiliated authors: FERRIANI, RUI ALBERTO - FMRP ; NOGUEIRA, ANTONIO ALBERTO - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.ics.2004.05.110
- Subjects: MIOMA (TRATAMENTO); GINECOLOGIA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: International Congress Series
- ISSN: 0531-5131
- Volume/Número/Paginação/Ano: v. 1271, p. 388-391, 2004
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
ROSA E SILVA, J. C. et al. Use of the levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas. International Congress Series, v. 1271, p. 388-391, 2004Tradução . . Disponível em: https://doi.org/10.1016/j.ics.2004.05.110. Acesso em: 16 abr. 2024. -
APA
Rosa e Silva, J. C., Rosa e Silva, A. C. J. S., Reis, F. J. C., Manetta, L. A., Ferriani, R. A., & Nogueira, A. A. (2004). Use of the levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas. International Congress Series, 1271, 388-391. doi:10.1016/j.ics.2004.05.110 -
NLM
Rosa e Silva JC, Rosa e Silva ACJS, Reis FJC, Manetta LA, Ferriani RA, Nogueira AA. Use of the levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas [Internet]. International Congress Series. 2004 ; 1271 388-391.[citado 2024 abr. 16 ] Available from: https://doi.org/10.1016/j.ics.2004.05.110 -
Vancouver
Rosa e Silva JC, Rosa e Silva ACJS, Reis FJC, Manetta LA, Ferriani RA, Nogueira AA. Use of the levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas [Internet]. International Congress Series. 2004 ; 1271 388-391.[citado 2024 abr. 16 ] Available from: https://doi.org/10.1016/j.ics.2004.05.110 - The levonorgestrel releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis
- Levonorgestrel intra-uterine device (Lng-IUD) reduces CA-125 serum levels in patients with pelvic endometriosis
- Effects of the levonorgestrel releasing intra-uterine system on uterine and ovarian volumes, endometrial thickness and dopplervelocimetry of uterine arteries, in women with pelvic endometriosis
- Routine office hysteroscopy in the investigation of infertile couples before assisted reproduction
- Use of levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas
- Comparative cell proliferation study in superficial and deep endometriotic lesions
- Levonorgestrel intra-uterine device effects on endometriosis
- Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue
- Uterine ultrasonographic changes during endometriosis treatment: a comparison between levonorgestrel-releasing intrauterine devices and a gonadotropin-releasing hormone agonist
- Increased expression of ID2, PRELP and SMOC2 genes in patients with endometriosis
Informações sobre o DOI: 10.1016/j.ics.2004.05.110 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
